前收市價 | 2.2200 |
開市 | 2.2100 |
買盤 | 2.1800 x 400 |
賣出價 | 2.2100 x 400 |
今日波幅 | 2.1600 - 2.2250 |
52 週波幅 | 2.1000 - 4.3000 |
成交量 | |
平均成交量 | 489,043 |
市值 | 218.171M |
Beta 值 (5 年,每月) | 1.47 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -0.1500 |
業績公佈日 | 2024年5月01日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 8.75 |
Atossa (ATOS) unveils positive results from its phase 2 EVANGELINE clinical study, which shows that (Z)-endoxifen can reduce the growth of ER+ breast cancer.
In this article, we will take a look at the 13 best penny stocks to buy according to billionaire Ken Griffin. To see more such companies, go directly to 5 Best Penny Stocks to Buy According to Billionaire Ken Griffin. The markets were off to an impressive start in 2024, driven by expectations that the […]
Accuray (ARAY) announces the latest data that supports the use of its CyberKnife System in the treatment of recurrent prostate cancer with stereotactic body radiation therapy.